The two clinic leaders, side by side
Families increasingly compare these two directly. They are more different than the category suggests — in protocol, pricing model, and how they handle evidence.
Both are leading in-person food allergy clinics running proprietary protocols — normally combinations of SLIT and OIT — with frequent visits and costs that can exceed $10,000 a year. The differences that matter: geography (FAI is Long Beach plus a New Jersey clinic from September 2026; Latitude runs about a dozen clinics across California and New York), pricing model (FAI publishes a monthly subscription of $979–$1,079; Latitude publishes no prices but works in-network with major insurers, with patients reporting a $4,000–$5,000+ non-covered program fee), pace (TIP publishes 2.5–4 years; Latitude describes 6–12 months to maintenance), and public reception (FAI’s record includes documented transparency criticism; Latitude’s public criticism is mostly limited to the program-fee surprise). Curex competes with both — verify everything against their sites.
Medically reviewed by Dr. Chet Tharpe, M.D. · Last reviewed September 2026
Side by side
The comparison, in their own published terms
| Food Allergy Institute | Latitude | |
|---|---|---|
| Protocol | TIP — proprietary; similar proteins first; SLIT+OIT combination | Proprietary OIT programs; multi-allergen; SLIT+OIT combination |
| Locations | Long Beach, CA (+ New Jersey from 15 Sept 2026) | ~12 clinics: SF Bay Area, LA/Orange County, NY metro |
| Published pace | 2.5–4 years to “food freedom” | 6–12 months active to maintenance; avg ~8.4 months |
| Pricing model | Published: $979–$1,079/month subscription | Unpublished; in-network visits + reported $4–5K+ program fee |
| Published outcome | “99% after completing TIP”; <1% reactions (self-reported) | 98% under 4 / 94% all ages (“internal data”); academic conference data on dose reactions |
| Public criticism themes | Transparency petition; BBB C+; evidence skepticism | Program-fee surprise; little else found |
| Ages | 15 months – 50 years | Publishes under-4 results; treats children and, case-by-case, adults |
Competitor figures are what each provider published on its own site or what patients reported publicly, dated where checked. Prices and policies change — confirm current figures with each provider, including us, before enrolling.
The honest read
Two serious clinics, differently shaped
In-person supervision and speed are real advantages, and both organisations deliver them. Latitude looks more conventional: insurer-integrated, multi-site, academically affiliated, with the shorter published timeline. FAI is the higher-conviction bet: a distinctive proprietary protocol, a longer arc, striking self-reported results, and a public record that includes both devoted graduates and documented calls for more transparency.
Neither is the wrong choice for the right family. And for the family that cannot make either schedule work — Curex is the only fully at-home food allergy program. Testing is done through local labs, at-home phlebotomy, or self-collection kits; doctors see patients via video visit or text message; and Allergychoices pharmacy ships the prescription treatment directly to the patient. The treatment is more gentle and generally a bit slower, but it has a much higher graduation rate because patients don’t drop out from negative side effects — and patients can generally save more than $10,000 over the course of treatment.
Curex competes in this market — we run the only fully at-home food allergy program — so read this page as a competitor’s honest summary of the public record and verify against the sources.
❓Frequently Asked Questions
Both are proprietary combinations of sublingual and oral immunotherapy under in-person supervision. TIP is distinctive in starting from structurally similar proteins before the allergen, across a published 2.5-to-4-year course toward “food freedom”. Latitude runs oral immunotherapy programs — including multi-allergen treatment and, historically, FDA-approved products alongside — describing 6–12 months of active treatment to reach maintenance, average about 8.4 months. Faster is not better for every patient; neither is longer.
Differently shaped rather than simply different sizes. FAI: published subscription of $979–$1,079 a month, out-of-pocket, with its own first-year estimates of roughly $11,700–$15,400; accepted PPOs for billable services; no Kaiser or HMOs. Latitude: no published prices; visits and diagnostics billed in-network with major insurers in each region; patients publicly report a one-time program fee of $4,000–$5,000+ that insurance does not cover. Either way the honest ask is identical: the all-in figure, in writing.
FAI publishes “99% success after completing TIP” and a sub-1% reaction rate — self-reported, with a small retrospective study as the main publication, and documented public skepticism. Latitude publishes 98% desensitisation for under-fours and 94% across ages, labelled by them as internal data, plus conference data from an academic collaboration showing about 5% of over a thousand OIT patients’ doses causing any reaction, overwhelmingly mild. Same reading skills apply to both: ask about denominators, definitions, and independent verification.
Reachability first: Latitude’s dozen clinics cover both coasts’ metro areas; FAI is Long Beach plus New Jersey from late 2026. Model second: a family wanting insurer-integrated billing and a shorter active phase may lean Latitude; one drawn to TIP’s similar-protein sequencing and willing to fund a longer subscription course may lean FAI. And a family for whom neither clinic’s schedule works has the at-home route — gentler, generally a bit slower, and without geography.
If you experience sudden difficulty breathing, throat swelling, or other signs of anaphylaxis, call 911. A prescribed epinephrine auto-injector is the first-line treatment — not antihistamines.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Keep reading
- Is Curex legit?The company, the evidence, and the concerns worth knowing — including full context on the 2025 FDA warning letter.Read
- How Curex worksThe treatment process end to end, from at-home testing to daily drops.Read
- Curex reviewsWhat patients actually report — both clusters, including the complaints.Read
- Is Curex worth the money?Plan pricing against allergy-shot costs, and who it is not worth it for.Read
- Evidence & guidelinesWhat the FDA approved, what the AAAAI/ACAAI practice parameter does and does not endorse, and what has been added since.Read
- Providers comparedCurex, Wyndly and Nectar on published prices, guarantees and evidence — including where a competitor is ahead.Read